Amplifon in the news

Amplifon, a global leader in hearing care services, was named one of the World's Top Companies for Women by Forbes.

Amplifon has been named one of Forbes' World's Top Companies for Women 2026, an international recognition for gender equality and inclusion based on employee surveys.

Amplifon's stock price and financial performance, including Q2 organic growth acceleration and H1 adjusted EBITDA increase, are in focus ahead of upcoming Q3 results and a shareholder meeting regarding the GN Hearing transaction on October 29.

Amplifon confirmed its 2026 growth goals after reporting increased first-half revenue, adjusted EBITDA, and cash flow, with the GN Hearing acquisition remaining a key strategic focus.

Amplifon is set to release its Q3 2026 results on October 29, with positive momentum and 2026 guidance expected.

AlphaValue/Baader Europe has upgraded Amplifon's stock rating to 'Buy' based on various financial, market, and ESG performance indicators.

AlphaValue/Baader Europe maintains its 'Buy' rating for Amplifon S.p.A. based on a comprehensive analysis of various financial and market performance indicators.

Intermonte confirms an 'outperform' rating for Amplifon, expecting continued market outperformance and improved profitability ahead of earnings and GN Hearing integration.

Amplifon's stock surged after AlphaValue upgraded its rating to 'buy' and raised its target price, citing a strong hearing aid market recovery and better-than-expected performance, with Equita also anticipating solid Q3 results.

AlphaValue/Baader Europe upgraded Amplifon to a 'Buy' rating, based on a comprehensive analysis of valuation, EPS revisions, fundamentals, and other financial metrics.

Amplifon S.p.A. received a "Buy" rating from AlphaValue/Baader Europe based on strong fundamental, valuation, and ESG performance.

FTSE MIB, Telecom Italia, and Amplifon all experienced stock declines, with Telecom Italia specifically affected by a network disruption.

Amplifon's stock rose 4.59% due to improved margins, with strong Q2 organic growth and upcoming Q3 results and a GN Hearing acquisition update.

Amplifon's stock rose 4.3% to 12 euros, showing potential for long positions despite vulnerable trends.

Amplifon's stock is under scrutiny as the company prepares for an October 29 shareholder meeting to approve the acquisition of GN Hearing, following strong first-half 2026 financial results with improved margins.

Amplifon's stock declined 1.95 percent on October 2, 2026, as analysts anticipate improved Q3 margins despite a slight revenue increase, following strong Q2 results and ahead of the October 29 earnings report.

Amplifon is experiencing its anticipated recovery, supported by strong composite and publication quality ratings.

Amplifon's stock recovered from a March 2026 low, driven by strong Q2 results and the upcoming acquisition of GN Hearing, with October 29 a critical date for Q3 results and acquisition approvals.

Jefferies confirms 'hold' rating for Amplifon, forecasting strong Q3 results and a 20.5% EBITDA margin, affirming positive full-year guidance.

Amplifon's proposed acquisition of GN Hearing is awaiting EU regulatory approval, while MLex offers regulatory intelligence services.